Home > Signaling Pathways>Metabolic Enzyme/Protease>RAR/RXR>IRX5183 (NRX195183, VTP195183, AGN195183)
IRX5183 (NRX195183, VTP195183, AGN195183)

This product is for research use only, not for human use. We do not sell to patients.

IRX5183 (NRX195183, VTP195183, AGN195183)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
100mg$2050Check With Us
200mg$3075Check With Us
500mg$5190Check With Us

Cat #: V22666 CAS #: 367273-07-2 Purity ≥ 99%

Description: IRX5183 (NRX-195183, VTP-195183, AGN-195183) is a potent, selective, and orally bioavailable retinoid acid receptor (RAR) alpha agonist with potential antineoplastic activity.

References: Beard RL, et al. Synthesis and biological activity of retinoic acid receptor-alpha specific amides. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3145-8.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)437.86
Molecular FormulaC22H22ClF2NO4
CAS No.367273-07-2
SMILES CodeO=C(O)C1=C(F)C=C(NC(C2=C(O)C(Cl)=C3C(C)(C)CCC(C)(C)C3=C2)=O)C=C1F           
SynonymsAGN-195183; AGN195183; AGN195183; IRX5183; IRX-5183; IRX 5183; NRX195183; NRX-195183; NRX 195183; VTP-195183; VTP195183; VTP 195183;
ProtocolIn VitroAGN-195183 (IRX-5183; Compound 4) inhibits the growth of breast cancer cell lines, and is inactive in an in vivo model of topical irritation. AGN-195183 and ATRA inhibit growth of the human breast cancer cell lines, T-47D and SK-BR-3. AGN-195183 does not cause the topical irritation induced by the RARa-selective retinoid, Am-580. AGN-195183 is currently in Phase I/IIA clinical trials in cancer patients.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM2.2838 mL11.4192 mL22.8384 mL45.6767 mL
5mM0.4568 mL2.2838 mL4.5677 mL9.1353 mL
10mM0.2284 mL1.1419 mL2.2838 mL4.5677 mL
20mM0.1142 mL0.5710 mL1.1419 mL2.2838 mL
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.